• Login
    View Item 
    •   NRU
    • Journal Publications
    • Medical and Health Sciences
    • Medical and Health Sciences
    • View Item
    •   NRU
    • Journal Publications
    • Medical and Health Sciences
    • Medical and Health Sciences
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    HIV-1 superinfection can occur in the presence of broadly neutralizing antibodies

    Thumbnail
    View/Open
    Article (1.922Mb)
    Date
    2018
    Author
    Serwanga, Jennifer
    Ssemwanga, Deogratius
    Muganga, Michael
    Nakiboneka, Ritah
    Nakubulwa, Susan
    Kiwuwa-Muyingo, Sylvia
    Morris, Lynn
    Redd, Andrew D.
    Quinn, Thomas C.
    Kaleebu, Pontiano
    Metadata
    Show full item record
    Abstract
    Superinfection of individuals already infected with HIV-1 suggests that pre-existing immune responses may not adequately protect against re-infection. We assessed high-risk female sex workers initially infected with HIV-1 clades A, D or A/D recombinants, to determine if HIV-1 broadly neutralizing antibodies were lacking prior to superinfection. Methods: Six superinfected female sex workers previously stratified by HIV-1 high-risk behavior, infecting virus clade and volunteer CD4 counts were evaluated at baseline (n = 5) and at 350 days post-superinfection (n = 6); one superinfected volunteer lacked pre-superinfection plasma. Retrospective plasmas were assessed for neutralization of a multi-clade panel of 12 HIV-1 viruses before superinfection, and then at quarterly intervals thereafter. Similarly stratified singly infected female sex workers were correspondingly assessed at baseline (n = 19) and 350 days after superinfection (n = 24). Neutralization of at least 50% of the 12 viruses (broad neutralization), and geometric means of the neutralization titers (IC50) were compared before and after superinfection; and were correlated with the volunteer HIV-1 superinfection status, CD4 counts, and pseudovirus clade. Results: Preexisting broad neutralization occurred in 80% (4/5) of the superinfected subjects with no further broadening by 350 days after superinfection. In one of the five subjects, HIV-1 superinfection occurred when broad neutralization was lacking; with subsequent broadening of neutralizing antibodies occuring within 9 months and plateauing by 30 months after detection of superinfection. Clade B and C pseudoviruses were more sensitive to neutralization (13; [87%]); and (12; [80%]) than the locally circulating clades A (10; [67%]) and D (6; [40%]), respectively (p = 0.025). Low antibody titers correlated with clade D viruses and with >500 CD4 T cell counts, but not with the superinfection status. Conclusion: These data demonstrate that HIV-1 superinfection can occur both in the presence, and in the absence of broadly neutralizing antibodies.
    URI
    https://doi.org/10.1016/j.vaccine.2017.11.075
    https://nru.uncst.go.ug/handle/123456789/4373
    Collections
    • Medical and Health Sciences [3011]

    Research Dissemination Platform copyright © since 2021  UNCST
    Contact Us | Send Feedback
    Partners
     

     

    Browse

    All of NRU
    Communities & CollectionsBy Issue DateAuthorsTitlesSubjects
    This Collection
    By Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    View Usage Statistics

    Research Dissemination Platform copyright © since 2021  UNCST
    Contact Us | Send Feedback
    Partners